Wave Life Sciences price target raised to $22 from $19 at B. Riley

B. Riley raised the firm’s price target on Wave Life Sciences (WVE) to $22 from $19 and keeps a Buy rating on the shares following the R&D day. The firm came away encouraged by deployment of Wave Life’s multiple platforms, “each of which could justify current valuation.”